Technical / White Paper
DRcaps® capsules achieve delayed release properties for nutritional ingredients in human clinical study
A gamma scintigraphic study of DRcaps® capsules in human subjects definitively documents that the specially formulated acid-resistant hydroxypropyl methylcellulose (HPMC) capsules are an “excellent choice” for delayed delivery of acid-sensitive ingredients like probiotics and enzymes. Data and images empirically demonstrate the capsules’ effective protection from early activation caused by stomach acids and, for a majority of study subjects, complete release in intestines where products such as probiotics and enzymes work best.
